jzp898
Generic: Interferon alpha (IFNα)·Code: JZP898, WTX-613
jzp898: 1 clinical trial tracked.
jzp898 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about jzp898, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
A Phase 1, First-in-human, Open-label, Multicenter Study of JZP898 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
Primary endpoint: Number of Participants with Dose Limiting Toxicities in Monotherapy and Combination Therapy
Interventionalopen177 targetStarted 2023-11Completion 2028-0510 sites · United StatesJazz Pharmaceuticals